[Prevention and treatment of bladder tumors recurrence with furtulon].
OBJECTIVE
To inquire into the value of oral furtulon therapy for bladder tumors.


METHODS
103 patients were randomized into four groups and have been undergoing a long term follow-ups.


RESULTS
Recurrent rate of oral furtulon therapy for bladder tumors (8.8%) and instillation of mitomycin C for preventing the recurrence of bladder tumors (12.5%) as compared to recurrent rate of control group(40%), which was statistically significant(P < 0.01). Overall, 4 patients (33.3%) had an effective response with furtulon.


CONCLUSIONS
Furtulon has more effective for treatment and prophylaxis of bladder tumors.
Wang
H
H
Department of Urology, PUMC Hospital, CAMS, PUMC, Beijing 100730, China.
Li
H
H
Zang
M
M
Xu
F
F
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D005467:Floxuridine / Q000008:administration & dosage*; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D016685:Mitomycin / Q000008:administration & dosage; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
D005467:Floxuridine; D016685:Mitomycin; C025034:doxifluridine